News
Medications known as GLP-1 inhibitors have made headlines in recent years due to their effectiveness in managing blood sugar ...
More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.
"It's called peptide YY (PYY). This molecule is also secreted by the gut after we eat a meal, and its job is to reduce appetite and slow the process of emptying food from the stomach, but via ...
These gastric peptides, including gastrin, ghrelin, gastrin-releasing peptide (GRP), and peptide YY (PYY), are thought to play pivotal roles in regulating digestive functions and other systemic ...
The 18-day ‘Eagles of Civilization 2025’ aerial drills between China and Egypt, which ran from Apr. 19 to May 4, 2025, saw the PLA Air Force’s YU-20/YY-20A ...
Image Credit: VAPOURTEC Ltd Published in a paper in Nature Communications entitled ‘Photochemically- enabled, post-translational production of C-terminal amides’, the process involved three steps: ...
The array simultaneously analyzed the following hormones: insulin, glucagon, C-Peptide 2, amylin (active), GIP (total), GLP-1 (active), ghrelin (active), leptin, pancreatic polypeptide (PP), and ...
This strategy was successfully applied to a recombinantly produced peptide YY analogue, achieving gram-scale synthesis. The findings highlight how flow photochemistry facilitates the development of ...
In recent years, peptide-based therapies have enjoyed a renaissance due to progress made in the world of chemical and structural biology. In addition, recent advances addressing the limitations of ...
CIN-110 is a potent, highly selective peptide YY (PYY 3-36) analog with an extended half-life, designed to significantly reduce the nausea and vomiting which has been observed with other PYY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results